Research Article

Survey of Torus Palatinus in Patients with End-Stage Renal Disease Undergoing Hemodialysis

Table 1

Baseline characteristics, laboratory findings, and dialysis-related data of hemodialysis patients with and without TP (n = 322).

VariableAll patients (n = 322)Patients with TP (n = 93)Patients without TP (n = 229)P value

Baseline characteristics
Age, year61.1 ± 11.857.8 ± 10.062.4 ± 12.30.001
Female gender, n (%)143 (44.4)56 (60.2)87 (38.0)<0.001
Hypertension, n (%)164 (50.9)48 (51.6)116 (50.7)0.876
Diabetes mellitus, n (%)114 (35.4)32 (34.4)82 (35.8)0.812
Dialysis duration, months107.1 ± 82.3103.6 ± 85.2108.6 ± 81.30.622
Alcohol consumption, n (%)11 (3.4)4 (4.3)7 (3.1)0.577
Betel nut chewing, n (%)12 (3.7)5 (5.4)7 (3.1)0.319
Cigarette habit, n (%)28 (8.6)7 (7.5)21 (9.2)0.635
Bruxism habit, n (%)33 (10.2)11 (11.8)22 (9.6)0.551

Laboratory findings
Blood urea nitrogen, mg/dL67.4 ± 17.768.9 ± 15.366.8 ± 18.60.341
Creatinine, mg/dL10.3 ± 2.110.4 ± 1.910.3 ± 2.10.566
Estimated glomerular filtration rate, mL/min/1.73 m24.8 ± 1.14.5 ± 1.14.8 ± 1.10.017
Uric acid, mg/dL6.7 ± 1.37.0 ± 1.26.7 ± 1.30.036
Sodium, mEq/L137.8 ± 2.8137.7 ± 2.8137.9 ± 2.80.716
Potassium, mEq/L4.7 ± 0.74.8 ± 0.64.6 ± 0.70.013
Chloride, mEq/L99.1 ± 2.999.1 ± 3.199.1 ± 2.80.925
Calcium, mg/dL9.7 ± 0.99.6 ± 0.99.7 ± 1.00.771
Phosphate, mg/dL5.0 ± 1.25.4 ± 1.14.9 ± 1.10.001
Bicarbonate, mmol/L21.7 ± 2.420.9 ± 2.422.0 ± 2.3<0.001
Fasting glucose, mg/dL117.0 ± 53.0114.5 ± 54.2118.0 ± 52.60.596
Albumin, g/dL4.0 ± 0.34.0 ± 0.33.9 ± 0.30.108
Alkaline phosphatase, U/L75.0 ± 41.373.5 ± 44.175.6 ± 40.20.684
Total cholesterol, mg/dL160.6 ± 33.2168.2 ± 33.3157.5 ± 32.80.009
High-density lipoprotein, mg/dL43.2 ± 14.242.8 ± 14.043.3 ± 14.30.750
Low-density lipoprotein, mg/dL106.2 ± 72.6110.6 ± 68.1104.4 ± 74.40.492
Triglyceride, mg/dL146.5 ± 117.0148.8 ± 105.3145.6 ± 121.60.826
Aspartate aminotransferase, U/L22.1 ± 8.922.3 ± 7.922.0 ± 9.20.813
Alanine aminotransferase, U/L17.5 ± 12.918.8 ± 13.416.9 ± 12.80.220
Gamma-glutamyl transferase, U/L32.2 ± 42.932.4 ± 45.732.1 ± 41.90.955
White blood cell count, 103/uL6.4 ± 1.96.8 ± 2.16.2 ± 1.80.014
Red blood cell count, 106/uL3.6 ± 0.53.6 ± 0.53.6 ± 0.60.339
Hemoglobin, g/dL10.4 ± 1.210.3 ± 1.210.5 ± 1.20.316
Hematocrit, %32.0 ± 3.631.7 ± 3.532.1 ± 3.60.335
Mean corpuscular volume, fL89.0 ± 7.589.1 ± 6.589.0 ± 7.90.903
Mean corpuscular hemoglobin, pg/Cell29.0 ± 2.829.0 ± 2.528.9 ± 3.00.928
Mean corpuscular hemoglobin concentration, gHb/dL32.5 ± 1.032.5 ± 0.932.5 ± 1.10.753
Red blood cell distribution width, %14.5 ± 1.414.4 ± 1.514.6 ± 1.30.135
Platelet count, 103/uL184.3 ± 63.7200.3 ± 61.8177.8 ± 63.40.004
Iron, ug/dL70.2 ± 53.676.1 ± 89.667.8 ± 28.10.208
Total iron binding capacity, ug/dL256.9 ± 49.8262.7 ± 50.2254.6 ± 49.50.186
Ferritin, ng/mL297.7 ± 300.4285.4 ± 242.4303.0 ± 321.30.634
Intact parathyroid hormone, pg/mL325.7 ± 311.4314.1 ± 298.1330.4 ± 317.10.671
High sensitivity C-reactive protein, mg/L6.9 ± 11.16.5 ± 10.27.1 ± 11.40.676

Dialysis related data
Residual glomerular filtration rate, mL/min3.5 ± 3.43.5 ± 3.43.5 ± 3.40.893
Urea reduction ratio0.8 ± 0.10.8 ± 0.10.8 ± 0.10.569
Kt/V1.8 ± 0.41.8 ± 0.31.8 ± 0.40.666
Time-averaged concentration of urea, mg/dL39.6 ± 9.840.5 ± 8.939.2 ± 10.10.288
Normalized protein catabolic rate, g/kg/day1.2 ± 0.41.2 ± 0.41.2 ± 0.40.617

TP: torus palatinus; P < .05, P < .01, and P < .001.